Stocksigma LogoStocksigma Logo

Brooks Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 1,925 (-17.9% YoY | -16.2% QoQ) ■ EBITDA: 32.0 (-87.3% YoY | -82.8% QoQ) ■ EBITDA Margin (%): 1.7 (-910 bps YoY | -645 bps QoQ) ■ PAT: 6,761

Brooks Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Brooks Laboratories Ltd · Outcome · 07 Nov 2026, 11:24 pm

Brooks Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 1,925 (-17.9% YoY | -16.2% QoQ) ■ EBITDA: 32.0 (-87.3% YoY | -82.8% QoQ) ■ EBITDA Margin (%): 1.7 (-910 bps YoY | -645 bps QoQ) ■ PAT: 6,761 (+747.6% YoY | Loss to Profit QoQ) ■ EPS (INR): 23.0 (+746.9% YoY | Loss to Profit QoQ) Brooks Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Trading ■ Revenue: 21.7 (-40.0% YoY | +17.1% QoQ) ■ EBIT: -5.6 (+60.6% YoY | +59.5% QoQ) ■ EBIT Margin (%): -25.7 (+1347 bps YoY | +4871 bps QoQ) Manufacturing ■ Revenue: 1,903 (-17.6% YoY | -16.4% QoQ) ■ EBIT: 99.9 (-62.9% YoY | -46.0% QoQ) ■ EBIT Margin (%): 5.2 (-642 bps YoY | -288 bps QoQ)

Original exchange filing (PDF)

More announcements from Brooks Laboratories Ltd

All Brooks Laboratories Ltd announcements